Fox Chase has been recognized as a Center of Excellence by the Myelodysplastic Syndromes Foundation, one of four such centers in Pennsylvania. This designation honors institutions with an established research and academic program in myelodysplastic syndromes (MDS); recognized expertise; the ability to conduct and make available genetic research; a history of publications on MDS; and ongoing research into the syndrome, including Institutional Review Board-approved clinical trials.
“As an MDS Center of Excellence, we offer patients with MDS state-of-the-art care,” says medical oncologist Patricia Kropf, MD, director of the Fox Chase-Temple MDS program. “We have clinical trials designed specifically for patients with MDS. Our care team includes clinicians, researchers, hematopathologists, and other staff members with expertise in MDS who are dedicated to the care of these patients.”